JUNIOR STRENGTH MOTRIN Drug Patent Profile

When do Junior Strength Motrin patents expire, and what generic alternatives are available?

Junior Strength Motrin is a drug marketed by J And J Consumer Inc and is included in two NDAs.

The generic ingredient in JUNIOR STRENGTH MOTRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Junior Strength Motrin

A generic version of JUNIOR STRENGTH MOTRIN was approved as ibuprofen by STRIDES PHARMA on September 24^th, 1986.

Summary for JUNIOR STRENGTH MOTRIN

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	208
Patent Applications:	3,852
DailyMed Link:	JUNIOR STRENGTH MOTRIN at DailyMed

US Patents and Regulatory Information for JUNIOR STRENGTH MOTRIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
J And J Consumer Inc	JUNIOR STRENGTH MOTRIN	ibuprofen	TABLET, CHEWABLE;ORAL	020601-003	Nov 15, 1996		DISCN	Yes	No
J And J Consumer Inc	JUNIOR STRENGTH MOTRIN	ibuprofen	TABLET;ORAL	020602-001	Jun 10, 1996		OTC	No	No

Expired US Patents for JUNIOR STRENGTH MOTRIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
J And J Consumer Inc	JUNIOR STRENGTH MOTRIN	ibuprofen	TABLET, CHEWABLE;ORAL	020601-003	Nov 15, 1996

EU/EMA Drug Approvals for JUNIOR STRENGTH MOTRIN

Company	Drugname	Inn	Product Number / Indication	Status	Generic	Biosimilar	Orphan	Marketing Authorisation	Marketing Refusal
Recordati Rare Diseases	Pedea	ibuprofen	EMEA/H/C/000549 Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.	Authorised	no	no	no	2004-07-28

International Patents for JUNIOR STRENGTH MOTRIN

See the table below for patents covering JUNIOR STRENGTH MOTRIN around the world.

Country	Patent Number	Title	Estimated Expiration
Greece	1001171	ΠΕΡΙΣΤΡΟΦΟΚΟΚΚΟΠΟΙΗΣΕΙΣ ΚΑΙ ΕΠΙΣΤΡΩΣΕΙΣ ΚΑΛΥΨΕΩΣ ΓΕΥΣΕΩΣ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΜΑΣΗΣΙΜΩΝ ΔΙΣΚΙΩΝ. (ROTOGRANULATIONS AND TASTE MASKING COATINGS FOR THE PREPARATION OF CHEWABLE TABLETS)
Greece	900100587
Australia	646399
Ireland	902823
Germany	69023183

Supplementary Protection Certificates for JUNIOR STRENGTH MOTRIN

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1781277	PA2024501	Lithuania		PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726

JUNIOR STRENGTH MOTRIN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Junior Strength Motrin

Introduction to Junior Strength Motrin

Junior Strength Motrin, a formulation of ibuprofen, is a widely used over-the-counter (OTC) medication designed for children. It is known for its anti-inflammatory, analgesic, and antipyretic properties, making it a staple in many households for treating various ailments such as fever, pain, and inflammatory conditions.

Global Ibuprofen Market Overview

The global ibuprofen market, which includes Junior Strength Motrin, is projected to experience steady growth over the coming years. Here are some key statistics:

• The global ibuprofen market was valued at USD 1.43 billion in 2023 and is estimated to reach USD 1.76 billion by 2032, growing at a CAGR of 2.44% during the forecast period (2024-2032)[3].
• Another estimate suggests the market was valued at USD 92.16 million in 2024 and is projected to reach USD 111.41 million by 2031, growing at a CAGR of 2.40% from 2024 to 2031[1].

Drivers of Market Growth

Several factors are driving the growth of the ibuprofen market, including:

Increasing Prevalence of Chronic Diseases

The rising incidence and prevalence of chronic diseases such as rheumatoid arthritis, osteoarthritis, cancer, and cardiovascular diseases are significant drivers. These conditions often require long-term management, increasing the demand for analgesic and anti-inflammatory medications like ibuprofen[1][3].

Growing Public Awareness and Urbanization

Public awareness about health and wellbeing, particularly in urban areas, is on the rise. This increased awareness, coupled with urbanization, leads to higher healthcare spending and a greater demand for OTC medications like Junior Strength Motrin[1][3].

Affordability and Availability

Ibuprofen is widely available in various forms, including tablets, capsules, powder, and syrups, making it accessible to a broad range of consumers. Its affordability further boosts its market growth[1].

Regional Market Analysis

North America

North America accounts for a significant share of the global ibuprofen market. The region's dominance is attributed to increased public awareness about health, a rising geriatric population, and high healthcare spending. The presence of major pharmaceutical companies in this region also contributes to its market share[1][3].

Asia Pacific

The Asia Pacific region is expected to witness substantial growth due to the increasing incidence of rheumatoid arthritis, rising healthcare expenditures, and the low cost of manufacturing in countries like China and India. India, in particular, is experiencing a significant aging population, which further amplifies the demand for ibuprofen[1][3].

Application Segments

The ibuprofen market, including Junior Strength Motrin, is segmented based on various applications:

Rheumatoid Arthritis and Osteoarthritis

These segments are expected to hold the largest revenue share due to the effective analgesic and anti-inflammatory properties of ibuprofen in treating rheumatic musculoskeletal disorders[1].

Cancer, Pain/Fever/Dysmenorrhea, and Inflammatory Diseases

Other significant application segments include cancer, pain/fever/dysmenorrhea, and inflammatory diseases. These conditions also drive the demand for ibuprofen due to its therapeutic benefits[1].

Challenges and Risks

Adverse Side Effects

Despite its benefits, ibuprofen is associated with adverse side effects, such as gastrointestinal issues, allergic reactions, and in rare cases, severe conditions like Stevens-Johnsons Syndrome. This has led to legal challenges and compensatory damages, as seen in the case of Children’s Motrin, where a $10 million verdict was awarded against the manufacturer due to severe side effects[2].

Regulatory and Legal Considerations

Manufacturers must comply with strict regulatory guidelines and labeling requirements to minimize the risk of adverse reactions. The FDA has specific contraindications and precautions listed for ibuprofen products, including hypersensitivity to ibuprofen and reactions similar to those experienced with aspirin or other NSAIDs[4].

Competitive Landscape

The global ibuprofen market is highly competitive, with several key players. Companies are focusing on strategic developments such as expanding product portfolios, enhancing distribution networks, and investing in research and development to improve the efficacy and safety of ibuprofen formulations.

Financial Trajectory

Given the steady growth rate and increasing demand, the financial trajectory for Junior Strength Motrin and the broader ibuprofen market looks promising. Here are some key financial projections:

• The market is expected to grow from USD 1.43 billion in 2023 to USD 1.76 billion by 2032, indicating a stable and growing revenue stream[3].
• The CAGR of 2.44% during the forecast period suggests a consistent increase in market value, driven by the factors mentioned above.

Key Takeaways

• The global ibuprofen market, including Junior Strength Motrin, is projected to grow steadily due to increasing chronic disease prevalence, public awareness, and urbanization.
• North America and the Asia Pacific are key regions driving market growth.
• The market faces challenges related to adverse side effects and regulatory compliance.
• Despite these challenges, the financial trajectory indicates a stable and growing market.

FAQs

1. What are the primary drivers of the global ibuprofen market?

The primary drivers include the increasing prevalence of chronic diseases, growing public awareness about health, rising urbanization, and increased healthcare spending.

2. Which region is expected to witness the most significant growth in the ibuprofen market?

The Asia Pacific region is expected to witness substantial growth due to the increasing incidence of rheumatoid arthritis, rising healthcare expenditures, and the low cost of manufacturing in countries like China and India.

3. What are the common applications of ibuprofen?

Common applications include treating rheumatoid arthritis, osteoarthritis, cancer, pain/fever/dysmenorrhea, inflammatory diseases, and headaches.

4. What are some of the adverse side effects associated with ibuprofen?

Adverse side effects include gastrointestinal issues, allergic reactions, and in rare cases, severe conditions like Stevens-Johnsons Syndrome.

5. How is the competitive landscape of the ibuprofen market?

The market is highly competitive with several key players focusing on strategic developments such as expanding product portfolios, enhancing distribution networks, and investing in research and development.

Cited Sources:

1. Verified Market Research: Ibuprofen Market Size, Share, Scope, Trends, Growth & Forecast.
2. Counsel Financial: $10M in Compensatory Damages Awarded Against Makers of Children's Motrin.
3. Straits Research: Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report.
4. FDA: MOTRIN® (ibuprofen) Suspension 100 mg/5 mL.